Myelofibrosis is a rare bone marrow disorder that disrupts the body's normal production of blood cells. Treatment for myelofibrosis depends on the severity and symptoms of the disease. Some of the drugs used in the treatment of myelofibrosis include: JAK inhibitors These drugs target the Janus kinase (JAK) pathway, which…
Los principales fármacos dirigidos para el mieloma múltiple (MM). Los medicamentos de terapia dirigida funcionan dirigiéndose a proteínas o procesos específicos en las células cancerosas mientras causan menos daño a las células normales. Algunos medicamentos dirigidos que se usan para el mieloma múltiple incluyen: El texto original en inglés es…
The main targeted drugs for multiple myeloma(MM). Targeted therapy drugs work by targeting specific proteins or processes in cancer cells while causing less damage to normal cells.Some targeted drugs used for multiple myeloma include: Proteasome inhibitors These drugs inhibit the protein complex called proteasome, which is responsible for degrading unwanted proteins…
Las terapias dirigidas son medicamentos que se dirigen específicamente a ciertas proteínas o mutaciones genéticas en las células cancerosas, lo que puede ayudar a retardar o detener su crecimiento. En el colangiocarcinoma, algunas de las terapias dirigidas que se han estudiado o utilizado incluyen: El texto original en inglés es…
Targeted therapies are drugs that specifically target certain proteins or genetic mutations in cancer cells, which can help to slow down or stop their growth. In cholangiocarcinoma, some of the targeted therapies that have been studied or used include: FGFR inhibitors Some cholangiocarcinomas have alterations in the FGFR2 gene. Drugs that target these…
Las principales terapias dirigidas para la Leucemia Mieloide Aguda (AML, por sus siglas en inglés) incluyen: El texto original en inglés es más preciso 10 targeted therapies for Acute Myeloid Leukemia[AML] Inhibidores de FLT3 Para AML con mutaciones FLT3, como midostaurina , gilteritinib, etc. Estos se dirigen a la tirosina…
The main targeted therapies for Acute Myeloid Leukemia (AML) include: FLT3 inhibitors For AML with FLT3 mutations, such as midostaurin, gilteritinib, etc. These target the FLT3 tyrosine kinase. Midostaurin[1] On April 28, 2017, the U.S. Food and Drug Administration approved midostaurin (RYDAPT, Novartis Pharmaceuticals Corp.) for the treatment of adult patients with newly diagnosed acute myeloid leukemia…
El 21 de marzo de 2023, LienTeh anunció una nueva estrategia de contenido destinada a proporcionar información y servicios de longevidad útiles, confiables y centrados en el usuario. Anteriormente, la Red LienTeh se creó originalmente para brindar apoyo durante la pandemia de COVID-19 al promover el equilibrio de atención médica…
On March 21, 2023, LienTeh announced a new content strategy aimed at providing useful, reliable and user-centric longevity information and services. Previously,The LienTeh Network was originally created to provide support during the COVID-19 pandemic by promoting cross-regional healthcare balance and improving access to healthcare resources. After that, the LienTeh network…
VIENTIANE, LAO PDR, March 6, 2023 -- The Lao Ministry of Health and the World Health Organization hosted an important GMP quality improvement meeting in Vientiane on March 1, attended by professionals from the local pharmaceutical industry. The purpose of this conference is to improve the quality of medicines in…